Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver

Human Gene Therapy

Volumn 7, Issue 13, 1996, Pages 1567-1576

  Ohwada, Akihiko ^a   Hirschowitz, Edward A ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CYTOSINE DEAMINASE; FLUCYTOSINE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; COLON CARCINOMA; CONTROLLED STUDY; DNA DETERMINATION; DOT HYBRIDIZATION; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEPATITIS; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER TOXICITY; LIVER TUMOR; METASTASIS; MOUSE; NONHUMAN; TUMOR NECROSIS;

EID: 0029743164     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.13-1567     Document Type: Article

References (48)

1. ANDERSEN, L., KILSTRUP, M., and NEUHARD, J. (1989). Pyrimidine, purine and nitrogen control of cytosine deaminase synthesis in Escherichia coli K 12 involvement of the GlnlG and purR genes in the regulation of codA expression. Arch. Microbiol. 152, 115-118.
2. ARNHEITER, H. (1980). Primary monolayer culture of adult mouse hepatocytes - a model for the study of hepatotropic viruses. Arch. Virol. 63, 11-22.
3. AUSTIN, E.A., and HUBER, B.E. (1993). A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharmacol. 43, 380-387.
4. BATZER, M.A., and DEININGER, P.L. (1991). A human-specific subfamily of alu sequences. Genomics 9, 481-487.
5. BENNETT, J. (1990). Antifungal agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. A.G. Gilman, T. Rall, A.S. Nies, and P. Taylor, eds. (Pergamon Press, New York) pp. 1165-1181.
6. BRODY, S.L., JAFFE, H.A., HAN, S.K., WERSTO, R.P., and CRYSTAL, R.G. (1994). Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum. Gene Ther. 5, 437-447.
7. BROWN, T. (1995). Dot and slot blotting of DNA. In Current Protocols in Molecular Biology. (John Wiley & Sons, Inc.) pp. 2.9.15-2.10.16.
8. CALABRESI, P., and CHABNER, B.A. (1990). Antineoplastic agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. A.G. Gilman, T. Rall, A.S. Nies, and P. Taylor, eds. (Pergamon Press, New York) pp. 1209-1263.
9. CHEN, S.H., SHINE, H.D., GOODMAN, J.C. GROSSMAN, R.G., and WOO, S.L. (1994). Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
10. CLAYMAN, G.L., EL-NAGGAR, A.K., ROTH, J.A. ZHANG, W.W., GOEPFERT, H., TAYLOR, D.L., and LIU, T.J. (1995). In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 55, 1-6.
11. COHEN, A.M., MINSKY, B.D., and SCHILSKY, R.L. (1993). Colon Cancer. In Cancer: Principles & Practice of Oncology. V.T.J. DeVita, S. Hellman, and S.A. Rosenberg, eds. (J.B. Lippincott Co., Philadelphia) pp. 929-997.
12. CORDIER, L., DUFFOUR, M.T., SABOURIN, J.C., LEE, M.G., CABANNES, J. RAGOT, T., PERRICAUDET, M., and HADDADA, H. (1995). Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther. 2, 16-21.
13. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
14. DRAZAN, K.E., SHEN, X.D., CSETE, M.E., ZHANG, W.W., ROTH, J.A., BUSUTTIL, R.W., and SHAKED, A. (1994). In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 116, 197-203.
15. FUJIWARA, T., GRIMM, E.A., MUKHOPADHYAY, T., ZHANG, W.W., OWEN-SCHAUB, L.B., and ROTH, J.A. (1994). Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54, 2287-2291.
16. GUNNING, P., PONTE, P., OKAYAMA, H., ENGEL, J., BLAU, H., and KEDES, L. (1983). Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol. 3, 787-795.
17. GUTIERREZ, A.A., LEMOINE, N.R., and SIKORA, K. (1992). Gene therapy for cancer. Lancet 339, 715-721.
18. HERSH, J., CRYSTAL, R.G., and BEWIG, B.B. (1995). Modulation of gene expression after replication deficient recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2, 124-131.
19. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90, 2812-2816.
20. HIRSCHOWITZ, E.H., OHWADA, A., PASCAL, W.R., RUSSI, T.J., and CRYSTAL, R.G. (1995). In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6, 1055-1063.
21. HOHN, D.C., STAGG, R.J., FRIEDMAN, M.A., HANNIGAN, J.F., JR., RAYNER, A., IGNOFFO, R.J., ACORD, P., and LEWIS, B.J. (1989). A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J. Clin. Oncol. 7, 1646-1654.
22. HUBER, B.E., RICHARDS, C.A., and KRENITSKY, T.A. (1991). Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA 88, 8039-8043.
23. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
24. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., DAVIS, S.T., and GOOD, S.S. (1994). Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA 91, 8302-8306.
25. KASS-EISLER, A., FALCK-PEDERSEN, E., ELFENBEIN, D.H., ALVIRA, M., BUTTRICK, P.M., and LEINWAND, L.A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1, 395-402.
26. KEMENY, N. (1992). Review of regional therapy of liver metastases in colorectal cancer. Semin. Oncol. 19, 155-162.
27. KEMENY, N., DALY, J., REICHMAN, B., GELLER, N., BOTET, J., and ODERMAN, P. (1987). Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann. Intern. Med. 107, 459-465.
28. KILSTRUP, M., MENG, L.M., NEUHARD, J., and NYGAARD, P. (1989). Genetic evidence for a repressor of synthesis of cytosine deaminase and purine biosynthesis enzymes in Escherichia coli. J. Bacteriol. 171, 2124-2127.
29. LI, Q., KAY, M.A., FINEGOLD, M., STRATFORD-PERRICAUDET, L.D., and WOO, S.L. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
30. LIU, T.J., ZHANG, W.W., TAYLOR, D.L., ROTH, J.A., GOEPFERT, H., and CLAYMAN, G.L. (1994). Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54, 3662-3667.
31. MARTIN, J.K., JR., O'CONNELL, M.J., WIEAND, H.S., FITZGIBBONS, R.J., JR., MAILLIARD, J.A., RUBIN, J., NAGORNEY, D.M., TSCHETTER, L.K., and KROOK, J.E. (1990). Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch. Surg. 125, 1022-1027.
32. MOOLTEN, F.L. (1994). Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther. 1, 279-287.
33. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA 89, 33-37.
34. MULLEN, C.A., COALE, M.M., LOWE, R., and BLAESE, R.M. (1994). Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54, 1503-1506.
35. NIEDERHUBER, J.E. (1993). Colon and rectum cancer. Patterns of spread and implications for workup. Cancer 71, 4187-4192.
36. RICHARDS, C.A., AUSTIN, E.A., and HUBER, B.E. (1995). Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther. 6, 881-893.
37. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAMA, M., STIER, L.E., PAAKKO, P.K., GILARDI, P., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., JALLAT, S., PAVIRANI, A., LECOCQ, J., and CRYSTAL, R.G. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
38. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
39. ROUGIER, P., LAPLANCHE, A., HUGUIER, M., HAY, J.M., OLLIVIER, J.M., ESCAT, J., SALMON, R., JULIEN, M., ROULLET, AUDY, J., GALLOT, D., GOUZI, J.L., PAILLER, J.L., ELISA, D., LACAINE, F., ROOS, S., ROTMAN, N., LUBOINSKI, M., and LASSER, P. (1992). Hepatic Arterial Infusion of Floxuridine in Patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J. Clin. Oncol. 10, 1112-1118.
40. SHEA, T.B. (1994). An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. BioTechniques 16, 1126.
41. SMYTHE, W.R., KAISER, L.R., HWANG, H.C., AMIN, K.M., PILEWSKI, J.M., ECK, S.J., WILSON, J.M., and ALBELDA, S.M. (1994). Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann. Thorac. Surg. 57, 1395-1401.
42. STRAUSS, W.M. (1995). Preparation of genomic DNA from mammalian tissue. In Current Protocols in Molecular Biology. (John Wiley & Sons, Inc.) pp. 2.2.1-2.2.3.
43. TRAPNELL, B.C. (1993). Quantitative evaluation of gene expression in freshly isolated human respiratory epithelial cells. Am. J. Physiol. 264, L199-212.
44. TRAPNELL, B.C., CHU, C.S., PAAKKO, P.K., BANKS, T.C., YOSHIMURA, K., FERRANS, V.J., CHERNICK, M.S., and CRYSTAL, R.G. (1991). Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc. Natl. Acad. Sci. USA 88, 6565-6569.
45. TURK, P.S., and WANEBO, H.J. (1993). Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 71, 4267-4277.
46. VAUGHN, D.J., and HALLER, D.G. (1993). Nonsurgical management of recurrent colorectal cancer. Cancer 71, 4278-4292.
47. WEIBEL, E.R., STAUBLI, W., GNAGI, H.R., and HESS, F.A. (1969). Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J. Cell. Biol. 42, 68-91.
48. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limites E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.